Acumen Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Acumen Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Acumen Pharmaceuticals Inc
Rating: 1.92758325
Author: Trendlyne DVM scores

about

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass...

1.97 -0.01 (-0.51%)

129.07% Gain from 52W Low

45,612

XNAS Volume

XNAS 06 Jan, 2026 10:48 AM (EST)

Not Eligible

Expensive Valuation

12.3 / 100

Technically Moderately Bullish

64.8 / 100

No estimates available

Acumen Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Acumen Pharma Inc Live Stock Price Today, Share Analysis and Chart

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass...

129.07% Gain from 52W Low

SWOT Analysis

Acumen Pharma Inc Live Price Chart